Sam Ang is a senior market access, pricing, reimbursement, and business development advisor with over 20 years of biopharma experience across global pharma and emerging biotech. He provides independent expert witness analysis and testimony.
His experience spans clinical development, launch planning, licensing, acquisition, commercial diligence, and portfolio decisions across oncology, rare disease, immunology, neuroscience, cardiometabolic disease, and specialty pharmaceuticals.
Specialized Expertise for Complex Commercial Disputes
Our specialized expertise covers pharmaceutical pricing, reimbursement, market access, and payer strategy, including managed care, pharmacy and medical benefit, formulary access, and international reference pricing. We provide support for commercial forecasting, damages, lost profits, product and asset valuation, business development, licensing, mergers and acquisitions, and commercial due diligence. Our experience extends to launch readiness, health economics, and global pricing and market access, with specific focus on oncology and rare diseases.
Ready to discuss your expert witness needs?
Contact us for availability and a preliminary conflicts check for your pharmaceutical commercial matter.